Sbi Securities Co., Ltd. Crispr Therapeutics Ag Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 7,738 shares of CRSP stock, worth $529,511. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,738
Previous 7,979
3.02%
Holding current value
$529,511
Previous $272 Million
38.62%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CRSP
# of Institutions
539Shares Held
68.7MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$697 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$383 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$252 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$224 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$195 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.34B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....